Chip maker Zoran Corp. and its subsidiary Oak Technology have added a number of defendants in their patent infringement suit against Taiwanese rivals MediaTek and Mintek in the U.S. District Court for the District of Central California.
The U.S. International Trade Commission has issued an initial determination that Taiwanese chip makers Media Reality Technologies, Inc. and Trumpion Microelectronics, Inc. both infringe a patent by U.S. rival Genesis Microchip.
The Canadian Senate has passed a bill that will allow generic drug manufacturers in Canada to produce copies of patented treatments for HIV, AIDS, tuberculosis and malaria and export them to resource-limited countries.
The Ministerial Council of the Organization for Economic Cooperation and Development (OECD) has approved a proposal by Japan to establish a large research group to study impact of intellectual property on sustainable growth.
Canada is expected to pass pioneering legislation Friday making it legal for cheap copies of patented medicines to be shipped to poor countries suffering from AIDS and other health crises.
The U.S. Patent Board of Appeals and Patent Interferences has issued judgment in favor of auto parts supplier ArvinMeritor against Eaton Corporation on all claims in two related transmission patent interferences, ArvinMeritor said.
Gateway has fired a legal salvo in the mounting patent battle between two of the world’s top computer maker, suing rival Hewlett-Packard Co. for infringement of five of its patents.
Expanding its patent litigation against one of its chief rivals, U.S. computer maker Hewlett-Packard has petitioned the U.S. International Trade Commission to block Gateway from importing computers.
Japan will propose the establishment of a specialized intellectual property body at the Organization for Economic Cooperation and Development (OECD), according to local media reports.
Canada’s legislature is expected to amend the country’s patent laws this week to let the government issue licenses to companies to produce generic versions of drugs for use in developing countries.
The U.S. Trade Representative has unveiled its closely watched annual list of countries considered the worst offenders of intellectual property rights.
South Korea has formally protested Japan’s ban on imports of Samsung SDI's plasma display panel screens, as patent litigation between Samsung and Fujitsu threatens to escalate to a trade dispute between the two countries.
Canada has amended proposed legislation to allow domestic drug-makers to export generic copies of patented HIV/AIDS drugs to the developing world, stripping patent holders of the “right of first refusal'” over contracts negotiated between developing countries and Canadian generics manufacturers.
In a surprise decision, Russia has adopted amendments to the copyright law that extend copyright protection to 70 years after the author’s death from the current 50 years.
The U.S. International Trade Commission is expected to ban imports of display controllers manufactured by Mstar Semiconductor after determining that the Taiwanese chip maker infringes a patent held by rival Genesis Microchip.
More than two years after China granted patent exclusivity for Pfizer’s Viagra anti-impotence drug, an onslaught of patent challenges has left the drug’s status in limbo, officials at China’s State Intellectual Property Office (SIPO) have conceded.
Ranbaxy has weighed in on Pfizer’s lawsuit against a website that sells a generic version of blockbuster cholesterol fighter Lipitor, demanding that the vendor stops selling generic drugs that have not been approved for sale in the United States.
Indian pharmaceutical companies have urged the government to pass legislation on data protection exclusivity.
The U.S. International Trade Commission has voted to begin an investigation into whether some imports of chips used in DVD players and computer optical storage devices infringe on patents held by two California firms.
Electronics makers Applica and Tilia have settled their litigation over patents for vacuum sealing in a deal under which Applica will pay royalties to use Tilia’s technology.